High precision, optimized yield, and full control over professional dosing protocols.
Nuvilab presents its new 60 mg and 30 mg Tirzepatide line in high-purity subcutaneous microdose vials.
Each ampoule undergoes rigorous sterility and stability testing to ensure predictable and safe performance.
Designed for professional use, the line delivers clinical precision, superior results, and maximum patient safety.
Signature:
Nuvilab — innovation that builds trust.
